Measurement Nt-proBNP circulating concentrations in heart failure patients with a new point-of-care assay

Clinical Laboratory

Volumn 59, Issue 7-8, 2013, Pages 831-835

  Lepoutre, Thibault ^a   Rousseau, Michel F ^a   Ahn, Sylvie A ^a   Gruson, Damien ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cardiac markers; Natriuretic peptides; NYHA; Severity

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ANALYZER; ANGIOGRAPHY; ARTICLE; BLOOD ANALYSIS EQUIPMENT; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; PROGNOSIS; RELIABILITY; THORAX RADIOGRAPHY;

BIOLOGICAL MARKERS; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POINT-OF-CARE SYSTEMS;

EID: 84883255945     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120418     Document Type: Article

References (12)

1. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. The New England Journal of Medicine 2002;347:161-7. (Pubitemid 34764819)
2. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601. (Pubitemid 34123434)
3. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7. (Pubitemid 34556391)
4. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. The New England Journal of Medicine 2001;345:1014-21.
5. Jernberg T, Stridsberg M, Venge P, Lindahl B. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. Journal of the American College of Cardiology 2002;40:437-45. (Pubitemid 34833157)
6. Tomonaga Y, Gutzwiller F, Lüscher TF, et al. Diagnostic accuracy of point-of-care testing for acute coronary syndromes, heart failure, and thromboembolic events in primary care: a cluster-randomised controlled trial, BMC family practice 2011;12:12.
7. Alehagen U, Janzon M. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting. European Journal of Heart Failure 2008;10:260-6.
8. Hjortshøj S, Venge P, Ravkilde J. Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays. Clinica Chimica Acta 2011;412:370-5.
9. Rawlins ML, Owen WE, Roberts WL. Performance characteristics of four automated natriuretic peptide assays. American Journal of Clinical Pathology 2005;123:439-45. (Pubitemid 40315086)
10. Januzzi JL, Jr, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. The American Journal of Cardiology 2005;95:948-54. (Pubitemid 40487743)
11. Yeo KT, Wu AH, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clinica chimica acta 2003;338:107-15. (Pubitemid 37456696)
12. Tang WH, Francis GS, Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clinical Biochemistry 2008;41:210-21. (Pubitemid 351246749)